nach oben

Erschienen in:

16.03.2023 | Psychiatrics • Original Article

Comparative efficacy of hypnotics in young and middle-aged adults with insomnia: a systematic review and network meta-analysis

verfasst von: Faizul Hasan, Hsin-Chien Lee, Pin-Yuan Chen, Yi-Han Wang, Lia Taurussia Yuliana, Debby Syahru Romadlon, Yu-Kang Tu, Hsiao-Yean Chiu

Erschienen in: Sleep and Breathing | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective/background

Insomnia is highly prevalent in modern society. However, the hierarchical selection of hypnotics in young and middle-aged adults with insomnia remains unclear. We aimed to compare the efficacy and daytime drowsiness associated with different hypnotics for treating insomnia in young and middle-aged adults.

Methods

We searched Embase, PubMed, Cochrane Library, and ProQuest Dissertations and Theses A&I databases from inception until December 15, 2021. We also manually searched reference lists and relevant publications. The literature search, data collection, and risk of bias evaluation were all carried out separately by pairs of reviewers. We included randomized control trials (RCTs) that compared hypnotics approved by the Food and Drug Administration. The R and Stata software were both used to perform the meta-analysis.

Results

In total, 117 RCTs comprising 22,508 participants with the age of 18 to 65 years were included. Assessment of the efficacy of the hypnotics and adverse events (drowsiness) revealed that zolpidem improved all objective sleep parameters (oTST, oSOL, oWASO, and oSE), zopiclone increased oTST and oSE and reduced oSOL, and daridorexant increased oTST and reduced oWASO. Regarding subjective sleep outcomes, zolpidem exhibited beneficial effects on sTST, sSOL, and sWASO. Zaleplon reduced sSOL, and zopiclone was the recommended hypnotic for improving SQ. Zolpidem was associated with drowsiness effect (odds ratio = 1.82; 95% confidence interval = 1.25 to 2.65). The results of sensitivity analysis remained unchanged after the exclusion of studies reporting long-term effects.

Conclusion

Zolpidem is recommended for managing sleep-onset insomnia and sleep maintenance insomnia but should be used with caution because of daytime drowsiness effects. Daridorexant is recommended as a promising agent for managing sleep maintenance insomnia.

Nur mit Berechtigung zugänglich

Adams RJ, Appleton SL, Taylor AW, Gill TK, Lang C, McEvoy RD et al (2017) Sleep health of Australian adults in 2016: results of the 2016 Sleep Health Foundation national survey. Sleep Health 3(1):35–42PubMedCrossRef

Cao XL, Wang SB, Zhong BL, Zhang L, Ungvari GS, Ng CH et al (2017) The prevalence of insomnia in the general population in China: a meta-analysis. PLoS One 12(2):e0170772PubMedPubMedCentralCrossRef

Itani O, Kaneita Y, Munezawa T, Mishima K, Jike M, Nakagome S et al (2016) Nationwide epidemiological study of insomnia in Japan. Sleep Med 25:130–138PubMedCrossRef

Kerkhof GA (2017) Epidemiology of sleep and sleep disorders in the Netherlands. Sleep Med 30:229–239PubMedCrossRef

Taiwan Society of Sleep Medicine (2017) The prevalence of common sleep problems in Taiwan: a 10 year cross-sectional study.http://www.tssm.org.tw/file/1494489550.pdf. Accessed 23 August 2022

Uhlig BL, Sand T, Ødegård SS, Hagen K (2014) Prevalence and associated factors of DSM-V insomnia in Norway: the Nord-Trøndelag Health Study (HUNT 3). Sleep Med 15(6):708–713PubMedCrossRef

Basta M, Simos P, Bertsias A, Duijker G, Zaganas I, Koutentaki E et al (2018) Association between insomnia symptoms and cognitive impairment in the Cretan Aging Cohort. Eur Geriatr Med 9(5):697–706PubMedCrossRef

Vargas I, Perlis ML (2020) Insomnia and depression: clinical associations and possible mechanistic links. Curr Opin Psychol 34:95–99PubMedCrossRef

Leger D, Bayon V, Ohayon MM, Philip P, Ement P, Metlaine A et al (2014) Insomnia and accidents: cross-sectional study (EQUINOX) on sleep-related home, work and car accidents in 5293 subjects with insomnia from 10 countries. J Sleep Res 23(2):143–152PubMedCrossRef

10.

Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD (2016) Physicians* CGCotACo. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 165(2):125–33PubMedCrossRef

11.

Riemann D, Baglioni C, Bassetti C, Bjorvatn B, DolencGroselj L, Ellis JG et al (2017) European guideline for the diagnosis and treatment of insomnia. J Sleep Res 26(6):675–700PubMedCrossRef

12.

Espie CA (2009) “Stepped care”: a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep 32(12):1549–1558PubMedPubMedCentralCrossRef

13.

Perils ML, Smith MT (2008) How can we make CBT-I and other BSM services widely available? J Clin Sleep Med 4(1):11–13PubMedCrossRef

14.

U.S. Food& Drug Administration (2019) Sleep disorder (sedative-hypnotic) drug information. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/sleep-disorder-sedative-hypnotic-drug-information. Accessed 23 August 2022

15.

Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M et al (2007) The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 22(9):1335–1350PubMedPubMedCentralCrossRef

16.

Holbrook AM, Crowther R, Lotter A, Cheng C, King D (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 162(2):225–233PubMedPubMedCentral

17.

Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN (2012) Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. The BMJ 345:e8343PubMedPubMedCentralCrossRef

18.

Kishi T, Matsunaga S, Iwata N (2015) Suvorexant for primary insomnia: a systematic review and meta-analysis of randomized placebo-controlled trials. PLoS One 10(8):e0136910PubMedPubMedCentralCrossRef

19.

Kuriyama A, Honda M, Hayashino Y (2014) Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis. Sleep Med 15(4):385–392PubMedCrossRef

20.

Kuriyama A, Tabata H (2017) Suvorexant for the treatment of primary insomnia: a systematic review and meta-analysis. Sleep Med Rev 35:1–7PubMedCrossRef

21.

Liu J, Wang LN (2012) Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis. Int J Clin Pract 66(9):867–873PubMedCrossRef

22.

Liu Y, Xu X, Dong M, Jia S, Wei Y (2017) Treatment of insomnia with tricyclic antidepressants: a meta-analysis of polysomnographic randomized controlled trials. Sleep Med 34:126–133PubMedCrossRef

23.

Nowell PD, Mazumdar S, Buysse DJ, Dew M, Reynolds CF et al (1997) Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 278(24):2170–7PubMedCrossRef

24.

Winkler A, Auer C, Doering BK, Rief W (2014) Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs 28(9):799–816PubMedCrossRef

25.

Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T (2004) Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 19(5):305–322PubMedCrossRef

26.

De Crescenzo F, D’Alò GL, Ostinelli EG, Ciabattini M, Di Franco V, Watanabe N et al (2022) Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. The Lancet 400(10347):170–184CrossRef

27.

Yue J-L, Chang X-W, Zheng J-W, Shi L, Xiang Y-J, Que J-Y et al (2023) Efficacy and tolerability of pharmacological treatments for insomnia in adults: a systematic review and network meta-analysis. Sleep Med Rev 68:101746. https://doi.org/10.1016/j.smrv.2023.101746

28.

Wang L, Pan Y, Ye C, Guo L, Luo S, Dai S et al (2021) A network meta-analysis of the long-and short-term efficacy of sleep medicines in adults and older adults. Neurosci Biobehav Rev 131:489–496PubMedCrossRef

29.

Lie JD, Tu KN, Shen DD, Wong BM (2015) Pharmacological treatment of insomnia. Pharma Ther 40(11):759

30.

Abad VC, Guilleminault C (2018) Insomnia in elderly patients: recommendations for pharmacological management. Drugs Aging 35(9):791–817PubMedCrossRef

31.

Neutel CI, Skurtveit S, Berg C (2012) What is the point of guidelines? Benzodiazepine and z-hypnotic use by an elderly population. Sleep Med 13(7):893–897PubMedCrossRef

32.

Chiu H-Y, Lee H-C, Liu J-W, Hua S-J, Chen P-Y, Tsai P-S et al (2021) Comparative efficacy and safety of hypnotics for insomnia in older adults: a systematic review and network meta-analysis. Sleep 44(5):zsaa260PubMedCrossRef

33.

Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777–784PubMedCrossRef

34.

Higgins JPT, Green Se (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011. The Cochrane Collaboration. www.cochrane-handbook.org. Accessed 23 August 2022

35.

Dujardin S, Pijpers A, Pevernagie D (2018) Prescription drugs used in insomnia. Sleep Med Clin 13(2):169–182PubMedCrossRef

36.

Varma S (2016) Benzodiazepines and hypnotics. Medicine 44(12):764–767CrossRef

37.

Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N (2006) Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 59(1):7–10PubMedCrossRef

38.

Su YX, Tu YK (2018) Statistical approaches to adjusting weights for dependent arms in network meta-analysis. Res Synth Methods 9(3):431–440PubMedCrossRef

39.

White IR, Barrett JK, Jackson D, Higgins JP (2012) Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Res Synth Methods 3(2):111–125PubMedPubMedCentralCrossRef

40.

Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G (2013) Graphical tools for network meta-analysis in STATA. PLoS One 8(10):e76654PubMedPubMedCentralCrossRef

41.

Lu G, Ades AE (2004) Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 23(20):3105–3124PubMedCrossRef

42.

White IR (2011) Multivariate random-effects meta-regression: updates to mvmeta. Stata Journal 11(2):255–270CrossRef

43.

Shim, S. R., Kim, S. J., Lee, J., & Rücker, G. (2019). Network meta-analysis: application and practice using R software. Epidemiol Health, 41:e2019013. https://doi.org/10.1016/j.smrv.2023.10174610.4178/epih.e2019013

44.

Papakonstantinou T, Nikolakopoulou A, Higgins JP, Egger M, Salanti G (2020) Cinema: software for semiautomated assessment of the confidence in the results of network meta-analysis. Campbell Syst Rev 16(1):e1080PubMedPubMedCentralCrossRef

45.

Nikolakopoulou A, Higgins JP, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M et al (2020) CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLoS Med 17(4):e1003082PubMedPubMedCentralCrossRef

46.

Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017) Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice guideline. J Clin Sleep Med 13(2):307–349PubMedPubMedCentralCrossRef

47.

Dolder CR, Nelson MH (2008) Hypnosedative-induced complex behaviours : incidence, mechanisms and management. CNS Drugs 22(12):1021–1036PubMedCrossRef

48.

Stallman HM, Kohler M, White J (2018) Medication induced sleepwalking: a systematic review. Sleep Med Rev 37:105–113PubMedCrossRef

49.

Dauvilliers Y, Zammit G, Fietze I, Mayleben D, SeboekKinter D, Pain S et al (2020) Daridorexant, a new dual orexin receptor antagonist to treat insomnia disorder. Ann Neurol 87(3):347–356PubMedCrossRef

50.

Xue T, Wu X, Chen S, Yang Y, Yan Z, Song Z et al (2022) The efficacy and safety of dual orexin receptor antagonists in primary insomnia: a systematic review and network meta-analysis. Sleep Med Rev 61:101573PubMedCrossRef

51.

Treiber A, de Kanter R, Roch C, Gatfield J, Boss C, von Raumer M et al (2017) The use of physiology-based pharmacokinetic and pharmacodynamic modeling in the discovery of the dual orexin receptor antagonist ACT-541468. J Pharmacol Exp Ther 362(3):489–503PubMedCrossRef

52.

U.S. Food % Drug Administration (2019) Public Notification: U-Dream Full Night contains hidden drug ingredient, December 18. https://www.fda.gov/drugs/medication-health-fraud/public-notification-u-dream-full-night-contains-hidden-drug-ingredient#:~:text=Zopiclone%20is%20a%20sedative%2D%20hypnotic,or%20next%20day%20after%20use. Accessed 23 August 2022

53.

Morin CM, Inoue Y, Kushida C, Poyares D, Winkelman J, Members GC (2021) Endorsement of European guideline for the diagnosis and treatment of insomnia by the World Sleep Society. Sleep Med 81:124–126PubMedCrossRef

54.

Sekhon BS (2013) Exploiting the power of stereochemistry in drugs: an overview of racemic and enantiopure drugs. J Mod Med Chem 1(10):10–36

55.

Najib, J. S. (2010). Efficacy and safety of zopiclone and eszopiclone in the treatment of primary and comorbid insomnia. GABA and Sleep: Molecular, Functional and Clinical Aspects. In: J.M. Monti et al. (eds.), GABA and Sleep.https://doi.org/10.1007/978-3-0346-0226-6_18, Springer Basel AG, pp 413-451

56.

Ho JH, Wood DM, Archer JR, Dargan PI (2015) Availability of prescription zopiclone over the internet. BMJ 351:h5710. https://doi.org/10.1136/bmj.h5710

Titel: Comparative efficacy of hypnotics in young and middle-aged adults with insomnia: a systematic review and network meta-analysis
verfasst von: Faizul Hasan
Hsin-Chien Lee
Pin-Yuan Chen
Yi-Han Wang
Lia Taurussia Yuliana
Debby Syahru Romadlon
Yu-Kang Tu
Hsiao-Yean Chiu
Publikationsdatum: 16.03.2023
Verlag: Springer International Publishing
Erschienen in: Sleep and Breathing / Ausgabe 5/2023
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-023-02812-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Objective/background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2023

Contribution of central sleep apnea to severe sleep apnea hypopnea syndrome

The association between sleep duration and risk of myopia in Chinese school-aged children: a cross-sectional study

Adherence to continuous positive airway pressure treatment in a cohort of elderly adults with newly diagnosed obstructive sleep apnea

Relationship between slow-wave sleep and serum γ-glutamine transaminase in non-obese men with obstructive sleep apnea–hypopnea syndrome

Kidney transplantation: a possible solution to obstructive sleep apnea in patients with end-stage kidney disease

Drug-induced sleep endoscopy-continuous positive airway pressure (DISE-CPAP), a newer modality to choose the right candidates for CPAP